Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan. [electronic resource]
Producer: 20180622Description: 710-717 p. digitalISSN:- 1440-1746
- 2-Naphthylamine
- Aged
- Aged, 80 and over
- Anilides -- administration & dosage
- Antiviral Agents -- administration & dosage
- Carbamates -- administration & dosage
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Lactams, Macrocyclic
- Macrocyclic Compounds -- administration & dosage
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Retrospective Studies
- Ribavirin -- administration & dosage
- Ritonavir -- administration & dosage
- Safety
- Sulfonamides -- administration & dosage
- Taiwan
- Treatment Outcome
- Uracil -- administration & dosage
- Valine
- Viral Load
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.